Adiponectin
الملخص
Adipose tissue is not considered anymore as a passive depot for storing excess energy in the form of
triglycerides but as an active organ secreting several hormones or adipokines. This review gives
some knowledge about history of discovery, ways of measurements, and biochemical and
pathophysiological effects of adiponectin.
المراجع
Tsao TS, Murrey HE, Hug C et al. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem. 2002; 277:29359-62.
Scherer PE, Williams S, Fogliano M et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995; 270: 26746-26749.
Maeda K, Okubo K, Shimomura I et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun. 1996; 221:286-289.
Choi-Miura NH, Tobe T, Sumiya J et al. Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. J Biochem. 1996; 119: 1157-65.
Nakano Y, Tobe T, Choi-Miura NH et al. Isolation and characterization of GBP2 8, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo). 1996; 120: 803-812.
Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996; 271: 10697- 10703.
Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Comm. 1999; 257:79–83.
Christian Weyer, Tohru Funahashi, Sachiyo Tanaka et al. Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia. The Journal of Clinical Endocrinology & Metabolism. 2001; 86: 1930-1935
Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000; 20: 1595-9.
Tobias Pischon, Cynthia J. Girman, Gokhan S. Hotamisligil, et al. Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men. JAMA. 2004;291:1730-1737
Tobias Pischon, Gökhan S. Hotamisligil and Eric B. Rimm. Adiponectin: Stability in Plasma over 36 Hours and Within-Person Variation over 1 Year Clinical Chemistry. 2003; 49: 650-652.
Yamauchi T, Kamon J, Ito Y et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.Nature. 2003; 423:762-9.
Tsuchida A, Yamauchi T, Ito Y et al. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem. 2004; 279:30817–30822.
Tsuchida A, Yamauchi T, Kadowaki T [Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor gamma, CREB-binding protein, and adiponectin. J Pharmacol Sci. 2005; 97: 164-70.
Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005; 26:439-51.
Takahata C, Miyoshi Y, Irahara N et al. Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett. 2007; 250: 229-36.
Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000;106:171–176.
Godoy-Matos AF, Bahia LR, Domingues RC et al. Adiponectin is related to intramyocellular lipid content in non-diabetic adults. J Endocrinol Invest. 2009 Jul 28. [Epub ahead of print].
Yamauchi T, Kamon J, Waki H et al. The fatderived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med.
; 7: 941–946.
Thamer C, Machann J, Tschritter O et al. Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans. Horm Metab Res. 2002; 34:646-9.
Yamauchi T, Waki H, Kamon J et al. Inhibition of RXR and PPAR ameliorates diet-induced obesity and type 2 diabetes. J Clin Invest. 2001; 108:1001–1013.
Berg AH, Combs TP, Du X et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001; 7:947– 953.
Combs TP, Berg AH, Obici S et al. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest. 2001; 108:1875–1881.
Lindsay RS, Funahashi T, Hanson RL et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002; 360:57–58.
Takashi Kadowaki and Toshimasa Yamauchi. Adiponectin and Adiponectin Receptors. Endocrine Reviews.2005; 26: 439-451.
Kubota N, Terauchi Y, Yamauchi T et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002; 277: 25863-6.
Fruebis J, Tsao TS, Javorschi S et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001; 98:2005-10.
Yamauchi T, Hara K, Kubota N et al. Dual roles of adiponectin/Acrp30 in vivo as an antidiabetic and anti-atherogenic adipokine. Curr Drug Targets Immune Endocr Metabol Disord. 2003; 3:243–254.
Ursula Meiera and Axel M. Gressner. Endocrine Regulation of Energy Metabolism: Review of Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin, Adiponectin, and Resistin. Clinical Chemistry. 2004; 50:1511-1525.
Myeong Jin Yoon1, Gha Young Lee1, Jun-Jae Chung1 et al. Adiponectin Increases Fatty Acid Oxidation in Skeletal Muscle Cells by Sequential Activation of AMP-ActivatedProtein Kinase, p38 Mitogen-Activated Protein Kinase, and Peroxisome Proliferator– Activated Receptor α. Diabetes. 2006; 55: 2562-2570.
Ouchi N, Kihara S, Arita Y, et al. Novel modulator of endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999; 100:2473–2476.
Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Comm.1999; 257:79-83.
Pena AS, Belobrajdic DP, Wiltshire E et al. Adiponectin relates to smooth muscle function and folate in obese children. Int J Pediatr Obes. 2009; 15:1-7.
Statnick MA, Beavers LS, Conner LJ et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res. 2000; 1: 81-8.
Zembala M, Asherson GL. Human Monocytes. London, England: Academic Press; 1989
Takafumi Yokota, Kenji Oritani, Isao Takahashi et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000; 96: 1723-1732.
Leah DiMascio, Carlijn Voermans, Mweia Uqoezwa et al. Identification of Adiponectin as a Novel Hemopoietic Stem Cell Growth Factor. The Journal of Immunology, 2007; 178: 3511-3520.
Garry A. Williams, Yu Wang, Karen E. Callon et al. In Vitro and in Vivo Effects of Adiponectin on Bone. Endocrinology. 2009; 150: 3603-3610.
Lam KS, Xu A. Adiponectin: protection of the endothelium. Curr Diab Rep. 2005; 5: 254-9.
Matsuzawa Y, Shimomura I, Kihara S et al. Importance of adipocytokines in obesityrelated diseases. Horm Res. 2003; 60 Suppl 3:56-9.
Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999; 100:2473–2476.
Kawano J, Arora R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr. 2009; 4: 44-9.
Ouchi N, Kihara S, Arita Y et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation. 2000; 102:1296–1301
Ouchi N, Kihara S, Arita Y et al. Adipocytederived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 2001; 103:1057–1063.
Funahashi T, Nakamura T, Shimomura I et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med. 1999; 38:202-6.
Arita Y, Kihara S, Ouchi N et al. Adipocytederived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation. 2002; 105:2893–2898.
Hui Chen, Monica Montagnani , Tohru Funahashi et al. Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells* J. Biol. Chem.2003; 278: 45021-45026.
Kobayashi H, Ouchi N, Kihara S et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res. 2004; 94:e27–e31.
Matsuda M, Shimomura I, Sata M et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. 2002; 277: 37487-37491.
Fernandez-Real JM, Lopez-Bermejo A, Casamitjina R et al. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Endocrinol Metab. 2003; 88: 2714-2718.
Aldhahi W, Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep. 2003; 3: 293-298.
Kawano J, Arora R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr. 2009; 4: 44-9.
